1296
Y. Wang et al. / Tetrahedron: Asymmetry 13 (2002) 1291–1297
4.13.
N-{(R)-[2-(Di-p-tolylphosphinoyl)naphthalen-1-
4.16. {(R)-[2-(Diphenylphosphanyl)naphthalen-1-
yl]phenylmethyl}-N-((1%R)-1%-phenylethyl)acetamide,
(R,R)-10b
yl]phenylmethyl}ethyl((1%R)-1%-phenylethyl)amine, (R,R)-
3c
Following the same procedure for the preparation of
(R,R)-6b, the coupling reaction of (R,R)-9 with di(4-
toly)phosphine oxide afforded (R,R)-10b (yield, 61%):
mp 244–245°C; [h]D20=+203.2 (c 0.57, CHCl3); 1H NMR
(300 MHz, CDCl3): l 2.02 (d, J=6.1 Hz, 3H), 2.30 (s,
3H), 2.39 (s, 3H), 2.44 (s, 3H), 4.58–4.60 (m, 1H), 6.15
(s, 1H), 6.85 (m, 1H), 7.04–7.28 (m, 12H), 7.38–7.43 (m,
2H), 7.52–7.58 (m, 4H), 7.70–7.77 (m, 4H), 8.25–8.26 (m,
1H); 31P NMR (121.46 MHz, CDCl3): l 34.2; IR (KBr
pellet): w 1658 (vs), 1600 (s), 1492 (m), 1420 (m), 1296 (s),
1181 (s), 1114 (s), 1098 (m), 809 (s), 758 (s), 698 (s), 663
(vs); EIMS (m/z): 502 ([M−105]+, 18%). Anal. calcd for
C41H38NO2P·0.5H2O: C, 79.85; H, 6.37; N, 2.27. Found:
C, 80.23; H, 6.45; N, 2.32%.
Following the same procedure for the preparation of
(R,R)-3a, the reduction of (R,R)-11a afforded (R,R)-3c
1
(yield, 51%): [h]2D0=−25.9 (c 0.525, CHCl3); H NMR
(300 MHz, CDCl3): l 0.57 (t, J=7.3 Hz, 3H), 1.49 (d,
J=6.7 Hz, 3H), 2.51–2.60 (m, 1H), 2.66–2.75 (m, 1H),
4.39 (q, J=6.7 Hz, 1H), 6.93–6.97 (m, 3H), 7.07–7.39 (m,
14H), 7.45–7.62 (m, 8H), 7.71 (d, J=8.6 Hz, 1H), 10.05
(d, J=9.2 Hz, 1H); 31P NMR (121.46 MHz, CDCl3): l
−14.4; IR (KBr pellet): w 3053 (w), 2967 (w), 1598 (w),
1584 (m), 1493 (m), 1450 (m), 1433 (s), 1180 (m), 1027
(m), 818 (s), 742 (vs), 696 (vs); EIMS (m/z): 549 ([M]+,
0.3%); ESIMS (m/z): 550.3 ([M+1]+, 100%); HRMS (EI)
calcd for C39H36NP: 549.2585. Found: 549.2583.
4.17. {(R)-[2-(Di-p-tolylphosphanyl)naphthalen-1-
4.14. {(R)-[2-(Diphenylphosphinoyl)naphthalen-1-
yl]phenylmethyl}ethyl((1%R)-1%-phenylethyl)amine, (R,R)-
11a
yl]phenylmethyl}ethyl((1%R)-1%-phenylethyl)amine, (R,R)-
3b
Following the same procedure for the preparation of
(R,R)-3a, the reduction of (R,R)-11b afforded (R,R)-3d
(yield, 56%): [h]2D0=+8.4 (c 0.515, CHCl3); 1H NMR (300
MHz, CDCl3): l 0.55 (t, J=7.2 Hz, 3H), 1.50 (d, J=6.9
Hz, 3H), 2.32 (s, 3H), 2.36 (s, 3H), 2.51–2.58 (m, 1H),
2.67–2.74 (m, 1H), 4.41 (q, J=6.9 Hz, 1H), 6.95–7.01 (m,
7H), 7.02–7.36 (m, 9H), 7.44–7.63 (m, 7H), 7.70–7.72 (m,
1H), 10.02 (d, J=8.6 Hz, 1H); 31P NMR (121.46 MHz,
CDCl3): l −16.2; IR (KBr pellet): w 3057 (w), 3027 (w),
2968 (m), 2920 (m), 1598 (m), 1495 (vs), 1449 (s), 1395
(m), 1375 (m), 1185 (m), 1089 (m), 1029 (m), 805 (vs),
699 (vs); EIMS (m/z): 577 ([M]+, 0.9%); ESIMS (m/z):
578.3 ([M+1]+, 100%); HRMS (EI) calcd for C41H40NP:
577.2898. Found: 577.2891.
To a solution of (R,R)-10a (552 mg, 0.953 mmol) in dried
THF (25 mL), was added BH3·Me2S (0.33 mL, 3.43
mmol) at 0°C. The reaction mixture was heated to reflux,
and stirred for additional 18 h. After cooling to room
temperature, the reaction was carefully quenched with
saturated aqueous NH4Cl and the mixture was extracted
with ethyl acetate. The organic phase was washed with
water, brine, dried over Na2SO4, and then concentrated
under reduced pressure. The residue was submitted to
chromatographic separation on silica gel with hexane/
EtOAc (4:1) as eluent to give a white amorphous solid
(509 mg, 95%): [h]D20=+57.9 (c 0.535, CHCl3); 1H NMR
(300 MHz, CDCl3): l 0.39 (t, J=7.0 Hz, 3H), 1.48 (d,
J=6.8 Hz, 3H), 2.46–2.62 (m, 2H), 4.39 (q, J=6.2 Hz,
1H), 6.90–7.00 (m, 4H), 7.08–7.73 (m, 22H), 10.23 (d,
J=8.8 Hz, 1H); 31P NMR (121.46 MHz, CDCl3): l 35.5;
IR (KBr pellet): w 3057 (w), 1598 (w), 1494 (m), 1437 (s),
1182 (s), 1115 (s), 818 (m), 750 (s), 721 (s), 698 (vs); EIMS
(m/z): 460 ([M−105]+, 79%). Anal. calcd for C39H36NOP:
C, 82.81; H, 6.41; N, 2.48. Found: C, 82.39; H, 6.71; N,
2.48%.
4.18. Typical procedure for Pd(0)-catalyzed asymmetric
allylic alkylation reaction
In a Schlenk tube containing 1,3-dipheylprop-2-en-1-yl
acetate ( )-12 (57 mg, 0.227 mmol), [Pd(C3H5)Cl]2 (2.1
mg, 0.0568 mmol, 2.5 mol%), (R,R)-3a (7.3 mg, 0.136
mmol, 6 mmol%), Cs2CO3 (148 mg, 0.45 mmol) was
added ClCH2CH2Cl (2 mL). The mixture was stirred at
room temperature for 20 min, and dimethyl malonate
(59.4 mg, 0.45 mmol) was then added. The reaction
mixture was allowed to stir at room temperature for 24
h. The reaction was quenched with saturated aqueous
NH4Cl, extracted with EtOAc (3×20 mL). The organic
phase was washed with saturated aqueous NaHCO3,
water, and brine, dried over Na2SO4, and concentrated
under reduced pressure. The residue was purified by
flash chromatography on silica gel with hexane/EtOAc
(4:1) as eluent to produce (S)-13 (73 mg, 99%) as a
colorless oil with 72.2% ee. 1H NMR (300 MHz,
CDCl3): l 3.52 (s, 3H), 3.69 (s, 3H), 3.97 (d, J=10.9
Hz, 1H), 4.27 (dd, J=10.9, 8.7 Hz, 1H), 6.34 (dd,
J=15.4, 8.4 Hz, 1H), 6.48 (d, J=15.8 Hz, 1H), 7.17–
7.24 (m, 10H). The enantiomeric excess was determined
by HPLC (Chiralpak AD, flow rate=1 mL/min, hex-
ane:iso-propanol=90:10, tR=12.6 min, tS=18.9 min).
4.15. {(R)-[2-(Di-p-tolylphosphinoyl)naphthalen-1-
yl]phenylmethyl}ethyl((1%R)-1%-phenylethyl)amine, (R,R)-
11b
Following the same procedure for the preparation of
(R,R)-11a, the reduction of (R,R)-10b afforded (R,R)-
11b (yield, 70%): [h]D20=+66.9 (c 0.495, CHCl3); 1H NMR
(300 MHz, CDCl3): l 0.38 (t, J=7.3 Hz, 3H), 1.49 (d,
J=6.7 Hz, 3H), 2.39 (s, 3H), 2.41 (s, 3H), 2.49–2.64 (m,
2H), 4.39 (q, J=6.1 Hz, 1H), 6.93–6.99 (m, 3H), 7.09–
7.36 (m, 8H), 7.45–7.64 (m, 8H), 7.67–7.72 (m, 5H), 10.21
(d, J=8.6 Hz, 1H); 31P NMR (121.46 MHz, CDCl3): l
35.5; IR (KBr pellet): w 1600 (m), 1494 (m), 1449 (m),
1398 (w), 1182 (vs), 1113 (vs), 1098 (s), 809 (s), 700 (s),
657 (s); EIMS (m/z): 488 ([M−105]+, 100%). Anal. calcd
for C41H40NOP: C, 82.94; H, 6.79; N, 2.36. Found: C,
82.46; H, 7.28; N, 2.37%.